Event

9th Semi-Annual Life Science Financial Forum

September 12, 2016

FDA partner Donna Lee Yesner will moderate a panel at the 9th Semi-Annual Life Science Financial Forum.

Impact of Pricing Pressures On Pharmaceutical Revenue & Profitability
Monday, September 12 | 1:30 pm

The pharmaceutical industry is facing tremendous pressure from patients, payers and providers to lower the cost of therapies, stimulating controversial discussions regarding the future impact of pricing on competition and profitability for manufacturers. How pharmaceutical companies respond to dropped pricing demands will ultimately affect the accessibility of products for patients and revenue generated from innovative drugs. With finance executives playing a greater role in operational decision-making, analyzing the factors that affect pricing decisions is of utmost importance.

Topics will include:

  • Importance of value propositions in light of pricing scrutiny
  • Effects of dropped pricing on access and profitability
  • Forecasting revenue in a price-sensitive healthcare environment